Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.
Pregnancy of singleton living fetus
Previous one or more cesarean sections
Gestational age: > 32 weeks
The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder wall", "utero-vesicalhypervascularity".
Maternal medical disorders e.g.: coagulation defects, cardiac diseases etc.….
Any known or reported hypersensitivity to the used medication.
All cases with spontaneous placental separation at laparotomy.
All patients undergoing conservative management of PAS.